Jeffrey S. Humphrey MD
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Jeffrey S. Humphrey MD
Lantheus Holdings, Inc. reported in an 8-K filed May 15, 2024 that Jeffrey S. Humphrey MD was appointed Chief Medical Officer, effective May 28, 2024.
“Jeffrey S. Humphrey, MD has been appointed Chief Medical Officer (CMO) and Jean-Claude Provost, MD has been named Chief Science Officer (CSO), effective May 28, 2024.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Lantheus Holdings, Inc. (LNTH)
SEC 8-K
Current2024-05-28–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Lantheus Holdings, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian Markison CEO, Chairman, Board Member
- Mary Anne Heino CEO, Chairman, Board Member
- Robert Marshall CFO
- Paul Blanchfield COO
- Daniel M. Niedzwiecki General Counsel
- Andrea Sabens Chief Accounting Officer
- Kimberly Brown Chief Accounting Officer
- Dr. Gérard Ber Board Member
- Dr. James H. Thrall Board Member
- Dr. Phuong Khanh (P.K.) Morrow Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.